Literature DB >> 19023105

Diabetic ketoacidosis: a current appraisal of pathophysiology and management.

Pulin B Koul1.   

Abstract

Diabetic ketoacidosis (DKA) is a frequent abnormal metabolic entity seen in high-dependency units such as critical care units and in the emergency department. Having an understanding of its pathophysiology, a consequence of absent to low insulin levels, delineates the clinical presentation. Most clinical features are caused by hyperglycemia and acidosis, including weight loss. The newer management modalities are discussed that include the need for intensive laboratory workup, meticulous monitoring of the insulin, and fluid management. Among the complications, cerebral edema (CE) is the most dreaded, albeit with low incidence. The new insights into its pathophysiology and management are outlined, and a timeline for management of DKA is proposed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19023105     DOI: 10.1177/0009922808323907

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  6 in total

1.  Effect of weight loss in adults on estimation of risk due to adiposity in a cohort study.

Authors:  Namgyal L Kyulo; Synnove F Knutsen; Gary E Fraser; Pramil N Singh
Journal:  Obesity (Silver Spring)       Date:  2011-09-22       Impact factor: 5.002

2.  Acidosis promotes cell apoptosis through the G protein-coupled receptor 4/CCAAT/enhancer-binding protein homologous protein pathway.

Authors:  Biao Dong; Xiaolu Zhang; Yafeng Fan; Songqiang Cao; Xuepei Zhang
Journal:  Oncol Lett       Date:  2018-09-21       Impact factor: 2.967

Review 3.  Life-saving decompressive craniectomy for diffuse cerebral edema during an episode of new-onset diabetic ketoacidosis: case report and review of the literature.

Authors:  Ha Son Nguyen; James D Callahan; Aaron A Cohen-Gadol
Journal:  Childs Nerv Syst       Date:  2010-09-21       Impact factor: 1.475

4.  Activation of GPR4 by acidosis increases endothelial cell adhesion through the cAMP/Epac pathway.

Authors:  Aishe Chen; Lixue Dong; Nancy R Leffler; Adam S Asch; Owen N Witte; Li V Yang
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

5.  Aversion to Hospital Admission Due to Fear of COVID Infection Leading to Fatality From Diabetic Ketoacidosis.

Authors:  Hasina Mohammad Ashraf; Trisha Sunderajan; Louisdon Pierre; Noah Kondamudi; Adebayo Adeyinka
Journal:  Cureus       Date:  2021-12-07

6.  The Impact of Inflammatory Bowel Disease on Mortality and Other Outcomes of Hospitalized Patients With Diabetic Ketoacidosis: An Observational Study of the United States National Inpatient Sample.

Authors:  Mohammad Aldiabat; Yazan Aljabiri; Yassine Kilani; Mubarak H Yusuf; Mohannad H Al-Khateeb; Ali Horoub; Farukhuddin Farukhuddin; Ratib Mahfouz; Adham E Obeidat
Journal:  Cureus       Date:  2022-09-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.